Comparison between five-year mortality of patients with and without red blood cell transfusion after percutaneous coronary intervention for ST-elevation acute myocardial infarction

Kardiologia Polska

Volumn 71, Issue 10, 2013, Pages 1029-1035

  Tajstra, Mateusz ^a   Ga̧sior, Mariusz ^a   Gierlotka, Marek ^a   Pres, Damian ^a   Hawranek, Michał ^a   Kuliczkowski, Wiktor ^a   Szkodziński, Janusz ^a   Poloński, Lech ^a  

^a MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Myocardial infarction; Percutaneous coronary intervention; Red blood cell transfusion

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; HEPARIN; MORPHINE; TICLOPIDINE;

ADULT; AGE DISTRIBUTION; AGED; ANEMIA; ARTICLE; BLOOD CLOT LYSIS; CARDIOGENIC SHOCK; CARDIOVASCULAR MORTALITY; CONTROLLED STUDY; DIABETES MELLITUS; ERYTHROCYTE TRANSFUSION; FEMALE; FOLLOW UP; GASTROINTESTINAL HEMORRHAGE; GLOMERULUS FILTRATION RATE; HEART LEFT BUNDLE BRANCH BLOCK; HEART LEFT VENTRICLE EJECTION FRACTION; HOSPITALIZATION; HUMAN; MAJOR CLINICAL STUDY; MALE; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; SEX DIFFERENCE; SMOKING; ST SEGMENT ELEVATION; ST SEGMENT ELEVATION MYOCARDIAL INFARCTION;

AGED; ANGIOPLASTY, BALLOON, CORONARY; ERYTHROCYTE TRANSFUSION; FEMALE; HOSPITAL MORTALITY; HUMANS; MALE; MYOCARDIAL INFARCTION; PERCUTANEOUS CORONARY INTERVENTION; PROGNOSIS; SURVIVAL RATE;

EID: 84888237911     PISSN: 00229032     EISSN: None     Source Type: Journal    
DOI: 10.5603/kp.2013.0257     Document Type: Article

References (37)

1. Alexander KP, Chen AY, Wang TY et al. Transfusion practice and outcomes in non-ST-segment elevation acute coronary syndromes. Am Heart J, 2008;155:1047-1053.
2. Rao SV, Jollis JG, Harrington RA et al. Relationship of blood transfusion and clinical outcomes in patients with acute coronary syndromes. JAMA, 2004;292:1555-1562.
3. Gasior M, Slonka G, Wilczek K et al. Comparison of invasive and non-invasive treatment strategies in older patients with acute myocardial infarction complicated by cardiogenic shock (from the Polish Registry of Acute Coronary Syndromes: PL-ACS). Am J Cardiol, 2011;107:30-36.
4. Nutritional Anemias. Report of a WHO scientific group. World Health Organisation, Geneva 1968.
5. Tajstra M, Gasior M, Gierlotka M et al. Comparison of five-year outcomes of patients with and without chronic total occlusion of noninfarct coronary artery after primary coronary intervention for ST-segment elevation acute myocardial infarction. Am J Cardiol, 2012;109:208-213.
6. Steg PG, James SK, Atar D et al. ESC Guidelines for the management of acute myocardial infarction in patients presenting with ST-segment elevation: the Task Force on the management of ST-segment elevation acute myocardial infarction of the European Society of Cardiology (ESC). Eur Heart J, 2012;33:2569-2619.
7. Wijns W, Kolh P, Danchin N et al. Guidelines on myocardial revascularization. The task force on myocardial revascularization of the European Society of Cardiology (ESC) and the European Association for Cardio-thoracic Surgery (EACTS). Eur Heart J, 2010;31:2501-2555.
8. Hamm CW, Bassand JP, Agewall S et al. ESC Guidelines for the management of acute coronary syndromes in patients presenting without persistent ST-segment elevation: the Task Force for the management of acute coronary syndromes (ACS) in patients presenting without persistent ST-segment elevation of the European Society of Cardiology (ESC). Eur Heart J, 2011;32:2999-3054.
9. Polonski L, Gasior M, Gierlotka M et al. A comparison of ST elevation versus non-ST elevation myocardial infarction outcomes in a large registry database: are non-ST myocardial infarctions associated with worse long-term prognoses? Int J Cardiol, 2011;152:70-77.
10. Arant CB, Wessel TR, Olson MB et al. National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. Hemoglobin level is an independent predictor for adverse cardiovascular outcomes in women undergoing evaluation for chest pain: results from the National Heart, Lung, and Blood Institute Women's Ischemia Syndrome Evaluation Study. J Am Coll Cardiol, 2004;43:2009-2014.
11. Nikolsky E, Aymong ED, Halkin A et al. Impact of anemia in patients with acute myocardial infarction undergoing primary percutaneous coronary intervention: analysis from the Controlled Abciximab and Device Investigation to Lower Late Angioplasty Complications (CADILLAC) Trial. J Am Coll Cardiol, 2004;44:547-553.
12. Vis MM, Sjauw KD, van der Schaaf RJ et al. Prognostic value of admission hemoglobin levels in ST-segment elevation myocardial infarction patients presenting with cardiogenic shock. Am J Cardiol, 2007;99:1201-1212.
13. Bassand JP, Afzal R, Eikelboom J et al. Relationship between baseline haemoglobin and major bleeding complications in acute coronary syndromes. Eur Heart J, 2010;31:50-58.
14. Bolińska S, Sobkowicz B, Zaniewska J et al. The significance of anaemia in patients with acute ST-elevation myocardial infarction undergoing primarypercutaneous coronary intervention. Kardiol Pol, 2011;69:33-39.
15. Kurek T, Lenarczyk R, Kowalczyk J et al. Effect of anemia in high-risk groups of patients with acute myocardial infarction treated with percutaneous coronary intervention. Am J Cardiol, 2010;105:611-618.
16. Rao MP, Boralessa H, Morgan C et al. Blood component use in critically ill patients. Anaesthesia, 2002;57:530-534.
17. Walsh TS, Garrioch M, Maciver C et al. Red cell requirements for intensive care units adhering to evidence-based transfusion guidelines. Transfusion, 2004;44:1405-1411.
18. Westbrook A, Pettila V, Nichol A et al. Transfusion practice and guidelines in Australian and New Zealand intensive care units. Intensive Care Med, 2010;36:1138-1146.
19. Hebert PC, Wells G, Martin C et al. Variation in red cell transfusion practice in the intensive care unit: a multicentre cohort study. Crit Care, 1999;3:57-63.
20. Jolicoeur EM, O'Neill WW, Hellkamp A et al; APEX-AMI Investigators. Transfusion and mortality in patients with ST-segment elevation myocardial infarction treated with primary percutaneous coronary intervention. Eur Heart J, 2009;30:2575-2583.
21. Figueras J, Monasterio Y, Lidón RM et al. Thrombin formation and fibrinolytic activity in patients with acute myocardial infarction or unstable angina: in-hospital course and relationship with recurrent angina at rest. J Am Coll Cardiol, 2000;36:2036-2043.
22. Manten A, de Winter RJ, Minnema MC et al. Procoagulant and proinflammatory activity in acute coronary syndromes. Cardiovasc Res, 1998;40:389-395.
23. Merlini PA, Bauer KA, Oltrona L et al. Persistent activation of coagulation mechanism in unstable angina and myocardial infarction. Circulation, 1994;90:61-68.
24. Minnema MC, Peters RJ, de Winter R et al. Activation of clotting factors XI and IX in patients with acute myocardial infarction. Arterioscler Thromb Vasc Biol, 2000;20:2489-2493.
25. Wu WC, Rathore SS, Wang Y et al. Blood transfusion in elderly patients with acute myocardial infarction. N Engl J Med, 2001;345:1230-1236.
26. Sabatine MS, Morrow DA, Giugliano RP et al. Association of hemoglobin levels with clinical outcomes in acute coronary syndromes. Circulation, 2005;111:2042-2049.
27. Yang X, Alexander KP, Chen AY et al.; CRUSADE Investigators. The implications of blood transfusions for patients with non-ST-segment elevation acute coronary syndromes: results from the CRUSADE National Quality Improvement Initiative. J Am Coll Cardiol, 2005;46:1490-1495.
28. Shishehbor MH, Madhwal S, Rajagopal V et al. Impact of blood transfusion on short- and long-term mortality in patients with ST-segment elevation myocardial infarction. J Am Coll Cardiol Cardiovasc Interv, 2009;2:46-53.
29. Kinnaird TD, Stabile E, Mintz GS et al. Incidence, predictors, and prognostic implications of bleeding and blood transfusion following percutaneous coronary interventions. Am J Cardiol, 2003;92:930-935.
30. Hendrickson JE, Hillyer CD. Noninfectious serious hazards of transfusion. Anesth Analg, 2009;108:759-769.
31. Benson AB, Moss M, Silliman CC. Transfusion-related acute lung injury (TRALI): a clinical review with emphasis on the critically ill. Br J Haematol, 2009;147:431-443.
32. Knowles S, Cohen H; on behalf of the Serious Hazards of Transfusion (SHOT) Steering Group: The 2010 Annual SHOT Report. [http://www.shotuk.org/wp- content/uploads/2011/07/SHOT-2010-Report.pdf].
33. Robinson SD, Janssen C, Fretz EB et al. Red blood cell storage duration and mortality in patients undergoing percutaneous coronary intervention. Am Heart J, 2010;159:876-881.
34. Eikelboom JW, Cook RJ, Liu Y, Heddle NM. Duration of red cell storage before transfusion and in-hospital mortality. Am Heart J, 2010;159:737-743.
35. Lelubre C, Piagnerelli M, Vincent JL. Association between duration of storage of transfused red blood cells and morbidity and mortality in adult patients: myth or reality? Transfusion, 2009;49:1384-1394.
36. Lacroix J, Hebert P, Fergusson D et al. The Age of Blood Evaluation (ABLE) randomized controlled trial: study design. Transfus Med Rev, 2011;25:197-205.
37. Steiner ME, Assmann SF, Levy JH et al. Addressing the question of the effect of RBC storage on clinical outcomes: The Red Cell Storage Duration Study (RECESS) (Section 7). Tranfus Apher Sci, 2010;43:107-116.